Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Plos One
|
January 12, 2016
HIV-1 A1 Subtype Epidemic in Italy Originated from Africa and Eastern Europe and Shows a High Frequency of Transmission Chains Involving Intravenous Drug Users
Alessia Lai, Giorgio Bozzi, Marco Franzetti, et al.
AIDS Research and Human Retroviruses
|
January 9, 2010
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy
Chiara Riva, Alessia Lai, Ilaria Caramma, et al.
Plos One
|
August 10, 2012
HIV-1 subtype F1 epidemiological networks among Italian heterosexual males are associated with introduction events from South America
Alessia Lai, Francesco R Simonetti, Gianguglielmo Zehender, et al.
International Journal of Antimicrobial Agents
|
December 6, 2014
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance
Giordano Madeddu, Giuseppe V L De Socio, Elena Ricci, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 6, 2021
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study
Marco Franzetti, Andrea Forastieri, Noemi Borsa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 26, 2013
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project)
Barbara Menzaghi, Elena Ricci, Laura Carenzi, et al.
Plos One
|
July 19, 2012
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience
Amedeo Capetti, Simona Landonio, Paola Meraviglia, et al.
International Journal of Antimicrobial Agents
|
December 10, 2013
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study
Amedeo Capetti, Paola Meraviglia, Simona Landonio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 8, 2025
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study
Matteo Augello, Francesca Di Bartolomeo, Benedetta Varisco, et al.
Chest
|
April 15, 2021
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
Giacomo Grasselli, Vittorio Scaravilli, Davide Mangioni, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Plos One
|
January 12, 2016
HIV-1 A1 Subtype Epidemic in Italy Originated from Africa and Eastern Europe and Shows a High Frequency of Transmission Chains Involving Intravenous Drug Users
Alessia Lai, Giorgio Bozzi, Marco Franzetti, et al.
AIDS Research and Human Retroviruses
|
January 9, 2010
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy
Chiara Riva, Alessia Lai, Ilaria Caramma, et al.
Plos One
|
August 10, 2012
HIV-1 subtype F1 epidemiological networks among Italian heterosexual males are associated with introduction events from South America
Alessia Lai, Francesco R Simonetti, Gianguglielmo Zehender, et al.
International Journal of Antimicrobial Agents
|
December 6, 2014
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance
Giordano Madeddu, Giuseppe V L De Socio, Elena Ricci, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 6, 2021
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study
Marco Franzetti, Andrea Forastieri, Noemi Borsa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
February 26, 2013
Safety and durability in a cohort of HIV-1 positive patients treated with once and twice daily darunavir-based therapy (SCOLTA Project)
Barbara Menzaghi, Elena Ricci, Laura Carenzi, et al.
Plos One
|
July 19, 2012
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience
Amedeo Capetti, Simona Landonio, Paola Meraviglia, et al.
International Journal of Antimicrobial Agents
|
December 10, 2013
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study
Amedeo Capetti, Paola Meraviglia, Simona Landonio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 8, 2025
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of Gram-negative bacterial infections: the multicentre retrospective CEFI-BAC study
Matteo Augello, Francesca Di Bartolomeo, Benedetta Varisco, et al.
Chest
|
April 15, 2021
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
Giacomo Grasselli, Vittorio Scaravilli, Davide Mangioni, et al.
Page
of 5